NAR Genomics and BioinformaticsBioinformaticsPeer-reviewed journal article
SUPREME: A cancer subtype prediction methodology integrating multiomics data using Graph Convolutional Neural Network
Abstract
To pave the road towards precision medicine in cancer, patients with highly similar biology ought to be grouped into the same cancer subtypes. Utilizing high-dimensional multiomics datasets, several integrative computational approaches have been developed to uncover cancer subtypes. Recently, Graph Neural Networks (GNNs) was discovered to learn node embeddings while utilizing node features and node associations at the same time on graph-structured data. Although there are some commonly used architectures such as Graph Convolutional Network (GCN) for cancer subtype prediction, the existing prediction tools have some limitations in leveraging those architectures with multiomics integration on multiple networks. Addressing them, we developed SUPREME (a subtype prediction methodology) by comprehensively analyzing multiomics data and associations between patients with graph convolutions on multiple patient similarity networks. Unlike the existing tools, SUPREME generates patient embeddings from patient similarity networks, on which it utilizes all the multiomics features. In addition, SUPREME integrates all the possible combinations of embeddings with the raw multiomics features to capture the complementary signals. Extensive evaluation of all combinations makes SUPREME interpretable in terms of utilized networks and features. On three different datasets from The Cancer Genome Atlas (TCGA), Molecular Taxonomy of Breast Cancer International Consortium (METABRIC), and both combined, our method significantly outperformed other integrative cancer (sub)type prediction tools and baseline methods, with overall consistent results. SUPREME-inferred subtypes had significant survival differences, mostly having more significance than ground truth (PAM50) labels, and outperformed nine cancer subtype differentiating tools and baseline methods. These results suggest that with proper utilization of multiple datatypes and patient associations, SUPREME could demystify the undiscovered characteristics in cancer subtypes that cause significant survival differences and could improve the ground truth label, which depends mainly on a single datatype. Source code for our tool is publicly available at https://github.com/bozdaglab/SUPREME.
- organism: human
- assay: bulk RNA-seq
- research focus: clustering
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: graph neural network
- approach: deep learning
- Citations
- 37
- FWCI
- 3.29
- Field percentile
- top 6%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Attention-based GCN Integrates Multi-omics Data for Breast Cancer Subtype Classification and Patient-specific Gene Marker Identification
Hui Guo, Xiang Lv, … Menglong Li·Briefings in Functional GenomicsPeer-reviewed·Mar 28, 2023
- Benchmarking Graph Neural Networks for Multi-Omics Cancer Subtyping using Methylation and Gene Expression Profiles
Julia Schirmacher, M. Mäurer, … Anne-Christin Hauschild·bioRxiv·Aug 25, 2026
- Integrative Network Fusion: a multi-omics approach in molecular profiling
Marco Chierici, Nicole Bussola, … Cesare Furlanello·Frontiers in OncologyPeer-reviewed·Jun 30, 2020
- Novel cancer subtyping method based on patient-specific gene regulatory network
Mai Adachi Nakazawa, Yoshinori Tamada, … Yasushi Okuno·Scientific ReportsPeer-reviewed·Dec 8, 2021
- DeepGraphMut: A graph-based deep learning methodfor cancer prognosis using somatic mutation profile
Aswin Jose, Akansha Srivastava, … Palakkad Krishnan Unni Vinod·Briefings in BioinformaticsPeer-reviewed·Jul 1, 2025
- MOGAT: An Improved Multi-Omics Integration Framework Using Graph Attention Networks
Raihanul Bari Tanvir, Md Mezbahul Islam, … Ananda Mohan Mondal·bioRxiv·Apr 1, 2023